April 2021 - BioMedWire (BMW)

FridayApr 30, 2021 1:50 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Is ‘One to Watch’

Tryp Therapeutics is a pharmaceutical company with a focus on developing clinical-stage compounds for diseases with high unmet medical needs through accelerated regulatory pathways The company currently has two drug candidates in development: TRP-8802 (targeting fibromyalgia, eating disorders and chronic pain conditions); and TRP-1001 (targeting soft tissue sarcomas) Through its PFN(TM) program, the company is focused on developing psilocybin-based drug therapies for certain neuropsychiatric disorders that offer increased efficacy and reduced risk of abuse or addiction The company’s management team has decades of experience in the life sciences industry, including the pharmaceutical and biotechnology markets Oncology therapeutics are expected to…

FridayApr 30, 2021 1:39 pm

United Medical Equipment Business Solutions Network Inc. Provides Solutions for Safer Workplaces

Routine virus testing is effective overall employer strategy for providing employee safety and business continuity More research needs to be done on how long vaccines are effective, if booster shots will be needed Only 26% of the U.S. is fully vaccinated; vaccinated individuals can still spread the virus United Medical Equipment Business Solutions Network provides solutions that fit the ever-changing needs of the nation’s workforce during the COVID-19 pandemic through the distribution of rapid antigen tests and COVID-19 rapid kit testing. As employers begin to reopen worksites, routine virus testing is an effective overall strategy for providing employee safety and…

FridayApr 30, 2021 11:12 am

Researchers Find Brain Damage in Coronavirus Patients

New research conducted by neuroradiologists, neurologists and neuropathologists from the Vagelos College of Physicians and Surgeons, Columbia University, has found that the virus that causes the coronavirus, the SARS-CoV-2, also causes considerable neurological damage to a patient’s brain. Study lead James E. Goldman stated that there has been a weighty debate about whether the ailment infects the brain. However, the study, which he conducted with assistant professor of neurology Kiran T. Thakur and professor Pater D. Canoll, who specializes in pathology and cell biology, showed no signs of the virus inside the brain cells of coronavirus patients. Goldman, who also…

ThursdayApr 29, 2021 3:00 pm

New Study Finds That Generations X, Y Display Poorer Health Trends

According to a recent study, Gen X and Y are demonstrating higher levels of unhealthy behaviors and poorer physical health, in comparison with older generations. The study was reported in the “American Journal of Epidemiology” on March 18, 2021. Since the 21st century begun, mortality and morbidity has been growing among younger and middle-aged Americans. Researchers from the Ohio State University, Columbus looked into these unfavorable trends to discover whether they extended to the younger generations and their basal behavioral, psychological and physiological mechanisms. The researchers — Paola Echave and Hui Zheng — studied trends in physical and mental health among two…

ThursdayApr 29, 2021 12:06 pm

Ryah Group Inc. Uses Big Data, AI to Reshape Plant-Based Medicine

RYAH recognizes the value data combined with analytics can bring to almost every industry. Company focused on becoming a technological leader in the plant-based treatment market. RYAH’s easy-to-operate line of products help foster a seamless dose-control experience that generates insightful data. A recent Forbes article called it the “oil” of the fourth industrial revolution (https://ibn.fm/x7inY) while a Gartner article noted it was a core function for businesses focused on success in 2021 (https://ibn.fm/wQ1Ht). Whatever it is called, data has become a hot commodity in today’s world, and the RYAH Group is dedicated to transforming patient care through big data and…

ThursdayApr 29, 2021 9:34 am

Burgeoning Plant-Based Health Products Market Holds Promise for Healthy Extracts Inc. (HYEX)

Healthy Extracts Inc. engages in proprietary R&D, sales and distribution of health products through its BergaMet North America and Ultimate Brain Nutrients (“UBN”) subsidiaries The global brain health supplements, UBN’s domain, is projected to grow at a CAGR of 8% from 2021 to 2028 The global heart health supplements market, BergaMet’s segment, is expected to witness a CAGR of 4.5% from 2020 to 2030 Overall, the global botanical and plant-derived drug market will potentially expand at a CAGR of 6.1% from 2017 to 2022 According to projections by various research firms, the global health products market is expected to continue…

WednesdayApr 28, 2021 1:44 pm

Researchers Identify Human Genes That Fight SARS-CoV-2 Infection

Researchers have determined which set of human genes help fight the infection that is known to cause COVID-19, the SARS-CoV-2. This information could be beneficial in helping researchers understand the factors that influence the ailment’s severity, in addition to assisting in the formulation of therapies for the said disease. The research was reported in the “Molecular Cell” journal. The genes, which were identified by researchers from the Sanford Burnham Prebys Medical Discovery Institute are associated with the cells that fight viruses in the body, known as interferons. The lead author of the study, Prof. Sumit K. Chanda, stated that the…

WednesdayApr 28, 2021 9:51 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Development is at the Forefront of Bladder Cancer Visualization Innovation

The i/Blue Imaging System’s(TM) development is the first to harness the power of white light and blue light visualization techniques with the added capability of displaying multiple images simultaneously which will help surgeons perform more accurate tumor resections Imagin Medical’s innovative system is currently in the manufacturing phase with Lighthouse Imaging with product completion slated for 2022 With its patented technology, the company is positioned to stake a claim on a $400 million segment of the $46 billion global endoscopy market Advancements in the way that cancer is diagnosed and treated continue to be made. On the forefront of new…

TuesdayApr 27, 2021 3:06 pm

Stanford Team Finds AI to Safely Include Study Subjects Who Could Have Been Ruled Out Previously

A group of scientists from Stanford University in collaboration with Genentech, a biotechnology corporation, has created a system based on AI that can be used to safely add participants to clinical trials that they may have previously been barred from. The group’s findings were reported in the “Nature” journal, with Columbia University’s James Rogers and Chunhua Weng publishing a “News & Views” piece on the group’s research in the same journal. Many countries have put in place measures to ensure that all drugs undergo clinical trials before being approved for use by patients in order to demonstrate that, in addition…

TuesdayApr 27, 2021 10:27 am

Brain Scientific Inc. (BRSF) Receives FDA Clearance for Next-Gen NeuroCap

BRSF announced it has FDA clearance for next-gen NeuroCap The newest version of the NeuroCap has added velcro strips, expanded size range to include pediatrics New device can stay on the patient’s head for up to four hours Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company, announced it has received clearance from the FDA for its next-generation NeuroCap(TM) (https://ibn.fm/RYmMH). This device is an advanced electroencephalogram (“EEG”) electrode array used in routine clinical and research settings. Like the previous version, the newest version of the NeuroCap will help improve patient access to neurological care through its simplicity, cost efficiency and one-time…